HTB

Meta-analysis of 18 ivermectin studies reports benefit

Simon Collins, HIV i-Base

A new meta analysis on the controversial question of whether ivermectin has a beneficial role in management of COVID-19 this time reports in it’s favour. [1]

This is in contrast to a recent randomised study reported in HTB that found no benefit in mild infection. [2]

Other large randomised studies are ongoing but likely to report soon.

References

  1. Kory P et al. Review of the emerging evidence demonstrating the efficacy of ivermectin in the prophylaxis and treatment of COVID-19. American Journal of Therapeutics. 2(3):e299-e318 doi: 10.1097/MJT.0000000000001377. (May/June 2021),
    https://journals.lww.com/americantherapeutics/Fulltext/2021/06000/Review_of_the_Emerging_Evidence_Demonstrating_the.4.aspx
  2. Ivermectin has no impact in treating mild COVID-19 in 400 adults in Columbia. HTB (12 March 2021).
    https://i-base.info/htb/40126

Links to other websites are current at date of posting but not maintained.